Simponi Aria (golimumab) is a tumor necrosis factor (TNF) blocker (or inhibitor). It's used to treat rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and polyarticular juvenile idiopathic arthritis (PJIA). Simponi Aria (golimumab) is given as an infusion into the veins typically once a month for 2 doses, then once every 2 months after that. Side effects of this medication include upper respiratory tract infections and rash.
Simponi Aria (golimumab) is a type of biologic disease-modifying antirheumatic drug (DMARD) that's classified as a tumor necrosis factor (TNF) blocker (or inhibitor). TNF is a protein in the body that plays a key role in inflammation. By blocking TNF, Simponi Aria (golimumab) lowers inflammation in your body to treat pain and swelling in your joints caused by autoimmune conditions.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Note: Side effects reported by people with RA who also took methotrexate at the same time.
Contact your healthcare provider immediately if you experience any of the following.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
More common
Body aches or pain
chills
difficulty with breathing
ear congestion
headache
loss of voice
muscle aches
stuffy or runny nose
trouble breathing
unusual tiredness or weakness
Less common
Blurred vision
burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
cough with mucus
dizziness
general feeling of discomfort or illness
hoarseness
joint pain
loss of appetite
nervousness
pain or tenderness around the eyes and cheekbones
painful cold sores or blisters on the lips
pounding in the ears
shivering
slow or fast heartbeat
sweating
tender, swollen glands in the neck
tightness in the chest
trouble with sleeping
trouble with swallowing
voice changes
vomiting
Rare
Bone pain
frequent or painful urination
redness, soreness, or itching of the skin
severe stomach pain
sores, welts, or blisters
yellow eyes or skin
Incidence not known
Hives, skin rash
puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
red, scaling, or crusted skin
swelling of the face, throat, or tongue
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
burning or stinging of the skin
difficulty having a bowel movement
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Both Simponi and Simponi Aria are brands that contain the same active ingredient, golimumab. Both medications are used for rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS). But Simponi is approved for ulcerative colitis (UC), while Simponi Aria is approved for polyarticular juvenile idiopathic arthritis (PJIA). Another difference is that Simponi is only approved for adults, but Simponi Aria can be used in children as young as 2 years old who have PsA and PJIA. Lastly, Simponi is given as an injection under the skin, whereas Simponi Aria is given as an infusion into the veins over 30 minutes. Talk to your healthcare professional (HCP) if you have specific questions about either brand.
Yes, Simponi Aria (golimumab) is a type of biologic medication, which is a type of medication that's made from living sources, like cells, in the lab. Simponi Aria (golimumab) is a monoclonal antibody, which is a lab-made protein that's made from cells.
No, Simponi Aria (golimumab) isn't a chemotherapy. Chemotherapy is a type of treatment that kills all fast-growing cells and is typically used to treat cancer. Instead, Simponi Aria (golimumab) is a TNF blocker that treats several autoimmune conditions by lowering the activity of the immune system.
How long it takes for Simponi Aria (golimumab) to work can differ from person to person, and might depend on what condition you're taking Simponi Aria (golimumab) to treat. Studies show people who took Simponi Aria (golimumab) for RA, PsA, and AS and pJIA started to work to relieve symptoms in as early as 2 weeks. But it might take 6 months to experience more noticeable benefits from the medication. Contact your prescriber if you're concerned with how quickly Simponi Aria (golimumab) starts to work.
It takes about 10 weeks for most of Simponi Aria (golimumab) to leave your body after a dose. This timeframe is estimated based on the half-life of Simponi Aria (golimumab) and can differ from person to person. Talk with your prescriber if you have more questions about how long this medication stays in your body.
Weight gain isn't an expected side effect of Simponi Aria (golimumab). But taking Simponi Aria (golimumab) can cause or worsen symptoms of heart failure, including weight gain due to fluid build-up. Speak with your prescriber right away if you experience unusual weight gain after starting Simponi Aria (golimumab).
Simponi Aria (golimumab) can cause certain side effects that lead to fatigue. For example, Simponi Aria (golimumab) can raise the risk for infections (e.g., cold, flu), heart failure symptoms, and lupus-like symptoms. All of these conditions can cause you to feel tired or fatigued. Let your healthcare team know if you feel a noticeable drop in your energy level after starting Simponi Aria (golimumab). They can examine you to better understand what might be causing your symptoms. If needed, they might ask you to pause Simponi Aria (golimumab) treatment.
No, hair loss wasn't a side effect reported by people using Simponi Aria (golimumab) in clinical studies. If you notice hair loss while you're taking Simponi Aria (golimumab), contact your healthcare team so they can help you figure out possible causes.
Simponi Aria (golimumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Simponi Aria (golimumab) can affect your body's ability to fight off infections. This raises your risk of serious or life-threatening bacterial, viral, or fungal infections. Your risk is higher if you’re already taking other medications that weaken your immune system (e.g., steroids, methotrexate). Before starting Simponi Aria (golimumab), tell your prescriber about your medical conditions and medications so they can make sure Simponi Aria (golimumab) is appropriate for you.
Treatment with Simponi Aria (golimumab) can also cause new or old tuberculosis (TB) infections to come back. Similarly, the medication can reactivate the hepatitis B virus (HBV) if you're a carrier of the virus. For these reasons, you'll need to get tested for both TB and HBV before starting Simponi Aria (golimumab) and get treatment if you test positive (meaning you're infected with TB or HBV).
If you develop symptoms of an infection (e.g., fever, cough, difficulty breathing, diarrhea, weakness, sweating, chills) while taking Simponi Aria (golimumab), get medical help right away. Your healthcare team might ask you to stop taking Simponi Aria (golimumab) so your body can fight the infection.
Though rare, people who took other tumor necrosis factor (TNF) blocker have reported developing certain types of cancers, including leukemia, lymphoma, and skin cancer. Because Simponi Aria (golimumab) is a TNF blocker, it might also raise the risk of getting cancers. The risk is higher for people who are younger than 18 years old, taking other medications that weaken your immune system (e.g., mercaptopurine, azathioprine (Imuran)), or have severe inflammatory conditions. Your prescriber will assess your risk before starting Simponi Aria (golimumab) and monitor you while you're taking it. If you experience symptoms, such as swollen lymph nodes in your neck, armpits, or groin, fatigue, weight loss, loss of appetite, frequent nosebleeds, or lumps on your skin, contact your prescriber.
Simponi Aria (golimumab) can cause new or worsening heart failure. Let your prescriber know if you currently have heart failure, since you’ll need to be closely monitored while taking this medication. If you have any new or worsening symptoms of heart failure (e.g., shortness of breath, swelling in your legs, ankles, or feet, irregular heartbeat, unable to exercise, tiredness or weakness) while taking Simponi Aria (golimumab), stop the medication and contact your HCP.
Although rare, TNF blockers like Simponi Aria (golimumab) have been linked to new or worsening nervous system problems. These problems can include nerve damage and multiple sclerosis. Tell your provider if you have any neurological problems before starting Simponi Aria (golimumab). Also let your HCP know if you get dizziness, muscle weakness or spasms, changes in vision, or loss of balance while you're taking Simponi Aria (golimumab).
Simponi Aria (golimumab) can cause a lupus-like syndrome, which is a condition where your body's immune system attacks itself. If this happens, you might experience flu-like symptoms, including fever and pain in your muscles and joints. Stop taking Simponi Aria (golimumab) and contact your prescriber if you have any of these symptoms. Once you stop taking the medication, your symptoms should go away.
Although rare, people taking TNF blockers like Simponi Aria (golimumab) have reported having low blood cell counts. This can raise the risk of serious infections, bleeding, and anemia. If your blood counts drop too low, you'll probably need to stop taking Simponi Aria (golimumab). If you develop any signs of infection (e.g., fever, tiredness, chills, cough, trouble breathing) or signs of blood problems (pale skin, fast heart rate, lightheadedness, blood in your urine or stool), contact your HCP right away.
Your healthcare team shouldn't prescribe Simponi Aria (golimumab) along with Kineret (anakinra) or Orencia (abatacept). Taking these medications together can raise the risk of serious side effects, including severe infections, without any additional benefits. Let your healthcare team know if you're already taking either Kineret (anakinra) or Orencia (abatacept) before starting Simponi Aria (golimumab).
Avoid getting live vaccines while you're taking Simponi Aria (golimumab) because there's a chance that you can get sick from them. Make sure you're up-to-date with vaccines before starting Simponi Aria (golimumab). Let the healthcare provider who's administering a vaccine to you that you're on Simponi Aria (golimumab). They'll double check to make sure it's safe for you to receive the vaccine.
Serious allergic reactions have been reported after using Simponi Aria (golimumab). These reactions can include rash, hives, trouble breathing, swelling of the face or lips, and anaphylaxis. Get medical help right away if you experience an allergic reaction to Simponi Aria (golimumab).
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 4ml of 50mg/4ml | 4 vials | $7,683.15 | $1,920.79 |
Simponi Aria (golimumab) is given as an infusion into the veins (intravenous or IV) over 30 minutes.
Note: Golimumab is also available as brand name Simponi, which is given as an injection under the skin (subcutaneous or SQ)
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.